- Home
- ZURA vs NAUT Comparison
ZURA vs NAUT Comparison
Compare ZURA & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- NAUT
- Stock Information
- Founded
- ZURA 2022
- NAUT 2016
- Country
- ZURA United States
- NAUT United States
- Employees
- ZURA N/A
- NAUT N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- ZURA Health Care
- NAUT Industrials
- Exchange
- ZURA Nasdaq
- NAUT Nasdaq
- Market Cap
- ZURA 69.9M
- NAUT 95.6M
- IPO Year
- ZURA N/A
- NAUT N/A
- Fundamental
- Price
- ZURA $1.90
- NAUT $0.72
- Analyst Decision
- ZURA Buy
- NAUT Strong Sell
- Analyst Count
- ZURA 10
- NAUT 1
- Target Price
- ZURA $12.67
- NAUT $1.75
- AVG Volume (30 Days)
- ZURA 292.6K
- NAUT 263.6K
- Earning Date
- ZURA 11-06-2025
- NAUT 10-28-2025
- Dividend Yield
- ZURA N/A
- NAUT N/A
- EPS Growth
- ZURA N/A
- NAUT N/A
- EPS
- ZURA N/A
- NAUT N/A
- Revenue
- ZURA N/A
- NAUT N/A
- Revenue This Year
- ZURA N/A
- NAUT N/A
- Revenue Next Year
- ZURA N/A
- NAUT N/A
- P/E Ratio
- ZURA N/A
- NAUT N/A
- Revenue Growth
- ZURA N/A
- NAUT N/A
- 52 Week Low
- ZURA $0.97
- NAUT $0.62
- 52 Week High
- ZURA $5.07
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- ZURA 48.83
- NAUT 51.79
- Support Level
- ZURA $1.88
- NAUT $0.70
- Resistance Level
- ZURA $2.19
- NAUT $0.80
- Average True Range (ATR)
- ZURA 0.14
- NAUT 0.05
- MACD
- ZURA -0.04
- NAUT 0.01
- Stochastic Oscillator
- ZURA 5.00
- NAUT 56.20
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.